Advances in precision medicine are transforming cancer treatment by enabling doctors to tailor therapies to the unique genetic and biological characteristics of individual tumors, according to oncologists at Medanta – The Medicity, Gurugram. Dr. KunjahariMedhi, Senior Director, Medical Oncology at MedantaGurugram, said cancer care has moved beyond the traditional one-size-fits-all approach. He noted that molecular profiling and genomic testing now allow clinicians to identify specific biomarkers and genetic signatures within tumors, helping them select treatments that are more effective, less toxic and better suited to each patient.
Highlighting recent breakthroughs, Dr. Medhi said immunotherapy is emerging as a powerful treatment option that strengthens the body’s immune system to recognize and destroy cancer cells. He added that the therapy is being successfully used in several cancers, including lung, kidney, colorectal, liver, breast, stomach, head and neck cancers, as well as melanoma. He also pointed to targeted therapies and antibody-drug conjugates (ADCs), which deliver anti-cancer drugs directly to cancer cells while minimizing damage to healthy tissues.Dr. Medhi stressed that early diagnosis remains critical, urging people not to ignore symptoms such as unexplained weight loss, prolonged cough, unusual bleeding or unexplained lumps.
In Guwahati, growing awareness about advanced cancer care is expected to boost demand for specialized oncology consultations and precision diagnostics in the region. Healthcare experts believe improved access to advanced treatment options, coupled with dedicated patient support services, could encourage more patients from Assam and the Northeast to seek timely cancer screening and treatment. Residents of Guwahati and nearby areas can consult Dr. Medhi on June 28 at Sunvalley Hospital, GS Road, Bormotoria. Medanta has also launched a dedicated Northeast helpline to assist patients with appointments and access to care in multiple regional languages.
